| No. |
Name Length
|
Chromosome No./Scaffold Id Scaffold Length |
BLAST (vs nr) |
Gene ontology |
| 9631 |
O_BomoSK1866_3prime_partial:A_BomoSK_comp4679_c0_seq2
419bp |
|
PREDICTED:_cyclin-dependent_kinase_14_[Bombyx_mori] |
| GO:0000086 |
P |
G2/M transition of mitotic cell cycle |
| GO:0000166 |
F |
nucleotide binding |
| GO:0000308 |
C |
cytoplasmic cyclin-dependent protein kinase holoenzyme complex |
| GO:0004672 |
F |
protein kinase activity |
| GO:0004674 |
F |
protein serine/threonine kinase activity |
| GO:0004693 |
F |
cyclin-dependent protein serine/threonine kinase activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005634 |
C |
nucleus |
| GO:0005737 |
C |
cytoplasm |
| GO:0005829 |
C |
cytosol |
| GO:0005886 |
C |
plasma membrane |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007049 |
P |
cell cycle |
| GO:0016020 |
C |
membrane |
| GO:0016055 |
P |
Wnt signaling pathway |
| GO:0016301 |
F |
kinase activity |
| GO:0016310 |
P |
phosphorylation |
| GO:0016740 |
F |
transferase activity |
| GO:0030332 |
F |
cyclin binding |
| GO:0051301 |
P |
cell division |
| GO:0051726 |
P |
regulation of cell cycle |
| GO:0060828 |
P |
regulation of canonical Wnt signaling pathway |
|
| 9632 |
O_BomoSK18670_3prime_partial:A_BomoSK_comp14156_c0_seq4
1644bp |
|
|
| GO:0003677 |
F |
DNA binding |
| GO:0005634 |
C |
nucleus |
| GO:0006325 |
P |
chromatin organization |
| GO:0006334 |
P |
nucleosome assembly |
| GO:0006338 |
P |
chromatin remodeling |
| GO:0006351 |
P |
transcription, DNA-templated |
| GO:0006355 |
P |
regulation of transcription, DNA-templated |
| GO:0006357 |
P |
regulation of transcription by RNA polymerase II |
| GO:0007095 |
P |
mitotic G2 DNA damage checkpoint signaling |
| GO:0007275 |
P |
multicellular organism development |
| GO:0008270 |
F |
zinc ion binding |
| GO:0010468 |
P |
regulation of gene expression |
| GO:0016568 |
P |
chromatin organization |
| GO:0016589 |
C |
NURF complex |
| GO:0016922 |
F |
nuclear receptor binding |
| GO:0019233 |
P |
sensory perception of pain |
| GO:0030097 |
P |
hemopoiesis |
| GO:0035064 |
F |
methylated histone binding |
| GO:0035073 |
P |
pupariation |
| GO:0035076 |
P |
ecdysone receptor-mediated signaling pathway |
| GO:0042766 |
P |
nucleosome mobilization |
| GO:0045747 |
P |
positive regulation of Notch signaling pathway |
| GO:0045824 |
P |
negative regulation of innate immune response |
| GO:0046331 |
P |
lateral inhibition |
| GO:0046426 |
P |
negative regulation of receptor signaling pathway via JAK-STAT |
| GO:0046872 |
F |
metal ion binding |
| GO:0048515 |
P |
spermatid differentiation |
| GO:0048813 |
P |
dendrite morphogenesis |
| GO:0070577 |
F |
lysine-acetylated histone binding |
| GO:0070615 |
F |
ATP-dependent chromatin remodeler activity |
|
| 9633 |
O_BomoSK18671_complete:A_BomoSK_comp14156_c0_seq4
283bp |
|
|
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005737 |
C |
cytoplasm |
| GO:0005829 |
C |
cytosol |
| GO:0006412 |
P |
translation |
| GO:0006418 |
P |
tRNA aminoacylation for protein translation |
| GO:0006915 |
P |
apoptotic process |
| GO:0007275 |
P |
multicellular organism development |
| GO:0008285 |
P |
negative regulation of cell population proliferation |
| GO:0016020 |
C |
membrane |
| GO:0030154 |
P |
cell differentiation |
| GO:0031398 |
P |
positive regulation of protein ubiquitination |
| GO:0060510 |
P |
type II pneumocyte differentiation |
| GO:1901216 |
P |
positive regulation of neuron death |
|
| 9634 |
O_BomoSK18672_internal:A_BomoSK_comp14157_c0_seq1
218bp |
|
|
|
| 9635 |
O_BomoSK18673_internal:A_BomoSK_comp14157_c0_seq2
336bp |
|
|
|
| 9636 |
O_BomoSK18674_complete:A_BomoSK_comp14158_c0_seq1
267bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004957 |
F |
prostaglandin E receptor activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006693 |
P |
prostaglandin metabolic process |
| GO:0007179 |
P |
transforming growth factor beta receptor signaling pathway |
| GO:0007565 |
P |
female pregnancy |
| GO:0007567 |
P |
parturition |
| GO:0008152 |
P |
metabolic process |
| GO:0016404 |
F |
15-hydroxyprostaglandin dehydrogenase (NAD+) activity |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0030728 |
P |
ovulation |
| GO:0045786 |
P |
negative regulation of cell cycle |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
| GO:0070403 |
F |
NAD+ binding |
| GO:0070493 |
P |
thrombin-activated receptor signaling pathway |
| GO:0097070 |
P |
ductus arteriosus closure |
|
| 9637 |
O_BomoSK18675_complete:A_BomoSK_comp14158_c0_seq2
119bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004957 |
F |
prostaglandin E receptor activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006693 |
P |
prostaglandin metabolic process |
| GO:0007179 |
P |
transforming growth factor beta receptor signaling pathway |
| GO:0007565 |
P |
female pregnancy |
| GO:0007567 |
P |
parturition |
| GO:0008152 |
P |
metabolic process |
| GO:0016404 |
F |
15-hydroxyprostaglandin dehydrogenase (NAD+) activity |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0030728 |
P |
ovulation |
| GO:0045786 |
P |
negative regulation of cell cycle |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
| GO:0070403 |
F |
NAD+ binding |
| GO:0070493 |
P |
thrombin-activated receptor signaling pathway |
| GO:0097070 |
P |
ductus arteriosus closure |
|
| 9638 |
O_BomoSK18676_3prime_partial:A_BomoSK_comp14158_c0_seq2
118bp |
|
|
| GO:0004022 |
F |
alcohol dehydrogenase (NAD+) activity |
| GO:0008152 |
P |
metabolic process |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
| 9639 |
O_BomoSK18677_complete:A_BomoSK_comp14158_c0_seq3
271bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004957 |
F |
prostaglandin E receptor activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006693 |
P |
prostaglandin metabolic process |
| GO:0007179 |
P |
transforming growth factor beta receptor signaling pathway |
| GO:0007565 |
P |
female pregnancy |
| GO:0007567 |
P |
parturition |
| GO:0008152 |
P |
metabolic process |
| GO:0016404 |
F |
15-hydroxyprostaglandin dehydrogenase (NAD+) activity |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0030728 |
P |
ovulation |
| GO:0045786 |
P |
negative regulation of cell cycle |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
| GO:0070403 |
F |
NAD+ binding |
| GO:0070493 |
P |
thrombin-activated receptor signaling pathway |
| GO:0097070 |
P |
ductus arteriosus closure |
|
| 9640 |
O_BomoSK18678_3prime_partial:A_BomoSK_comp14158_c0_seq4
118bp |
|
|
| GO:0004022 |
F |
alcohol dehydrogenase (NAD+) activity |
| GO:0008152 |
P |
metabolic process |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
| 9641 |
O_BomoSK18679_complete:A_BomoSK_comp14158_c0_seq4
115bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004957 |
F |
prostaglandin E receptor activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006693 |
P |
prostaglandin metabolic process |
| GO:0007179 |
P |
transforming growth factor beta receptor signaling pathway |
| GO:0007565 |
P |
female pregnancy |
| GO:0007567 |
P |
parturition |
| GO:0008152 |
P |
metabolic process |
| GO:0016404 |
F |
15-hydroxyprostaglandin dehydrogenase (NAD+) activity |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0030728 |
P |
ovulation |
| GO:0045786 |
P |
negative regulation of cell cycle |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
| GO:0070403 |
F |
NAD+ binding |
| GO:0070493 |
P |
thrombin-activated receptor signaling pathway |
| GO:0097070 |
P |
ductus arteriosus closure |
|
| 9642 |
O_BomoSK1867_complete:A_BomoSK_comp4680_c0_seq1
122bp |
|
|
|
| 9643 |
O_BomoSK18680_complete:A_BomoSK_comp14158_c0_seq5
145bp |
|
|
| GO:0004022 |
F |
alcohol dehydrogenase (NAD+) activity |
| GO:0008152 |
P |
metabolic process |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
| 9644 |
O_BomoSK18681_complete:A_BomoSK_comp14158_c0_seq5
115bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004957 |
F |
prostaglandin E receptor activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006693 |
P |
prostaglandin metabolic process |
| GO:0007179 |
P |
transforming growth factor beta receptor signaling pathway |
| GO:0007565 |
P |
female pregnancy |
| GO:0007567 |
P |
parturition |
| GO:0008152 |
P |
metabolic process |
| GO:0016404 |
F |
15-hydroxyprostaglandin dehydrogenase (NAD+) activity |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0030728 |
P |
ovulation |
| GO:0045786 |
P |
negative regulation of cell cycle |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
| GO:0070403 |
F |
NAD+ binding |
| GO:0070493 |
P |
thrombin-activated receptor signaling pathway |
| GO:0097070 |
P |
ductus arteriosus closure |
|
| 9645 |
O_BomoSK18682_complete:A_BomoSK_comp14158_c0_seq6
145bp |
|
|
| GO:0004022 |
F |
alcohol dehydrogenase (NAD+) activity |
| GO:0008152 |
P |
metabolic process |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
| 9646 |
O_BomoSK18683_complete:A_BomoSK_comp14158_c0_seq6
119bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004957 |
F |
prostaglandin E receptor activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006693 |
P |
prostaglandin metabolic process |
| GO:0007179 |
P |
transforming growth factor beta receptor signaling pathway |
| GO:0007565 |
P |
female pregnancy |
| GO:0007567 |
P |
parturition |
| GO:0008152 |
P |
metabolic process |
| GO:0016404 |
F |
15-hydroxyprostaglandin dehydrogenase (NAD+) activity |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0030728 |
P |
ovulation |
| GO:0045786 |
P |
negative regulation of cell cycle |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
| GO:0070403 |
F |
NAD+ binding |
| GO:0070493 |
P |
thrombin-activated receptor signaling pathway |
| GO:0097070 |
P |
ductus arteriosus closure |
|
| 9647 |
O_BomoSK18684_3prime_partial:A_BomoSK_comp14158_c0_seq7
240bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004957 |
F |
prostaglandin E receptor activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006693 |
P |
prostaglandin metabolic process |
| GO:0007179 |
P |
transforming growth factor beta receptor signaling pathway |
| GO:0007565 |
P |
female pregnancy |
| GO:0007567 |
P |
parturition |
| GO:0008152 |
P |
metabolic process |
| GO:0016404 |
F |
15-hydroxyprostaglandin dehydrogenase (NAD+) activity |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0030728 |
P |
ovulation |
| GO:0045786 |
P |
negative regulation of cell cycle |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
| GO:0070403 |
F |
NAD+ binding |
| GO:0070493 |
P |
thrombin-activated receptor signaling pathway |
| GO:0097070 |
P |
ductus arteriosus closure |
|
| 9648 |
O_BomoSK18685_3prime_partial:A_BomoSK_comp14158_c0_seq8
244bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004957 |
F |
prostaglandin E receptor activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006693 |
P |
prostaglandin metabolic process |
| GO:0007179 |
P |
transforming growth factor beta receptor signaling pathway |
| GO:0007565 |
P |
female pregnancy |
| GO:0007567 |
P |
parturition |
| GO:0008152 |
P |
metabolic process |
| GO:0016404 |
F |
15-hydroxyprostaglandin dehydrogenase (NAD+) activity |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0030728 |
P |
ovulation |
| GO:0045786 |
P |
negative regulation of cell cycle |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
| GO:0070403 |
F |
NAD+ binding |
| GO:0070493 |
P |
thrombin-activated receptor signaling pathway |
| GO:0097070 |
P |
ductus arteriosus closure |
|
| 9649 |
O_BomoSK18686_3prime_partial:A_BomoSK_comp14159_c0_seq1
1266bp |
|
|
| GO:0003674 |
F |
molecular_function |
| GO:0008150 |
P |
biological_process |
|
| 9650 |
O_BomoSK18687_5prime_partial:A_BomoSK_comp14159_c0_seq1
433bp |
|
|
|
| 9651 |
O_BomoSK18688_complete:A_BomoSK_comp14159_c0_seq1
207bp |
|
|
|
| 9652 |
O_BomoSK18689_complete:A_BomoSK_comp14159_c0_seq1
189bp |
|
|
|
| 9653 |
O_BomoSK1868_5prime_partial:A_BomoSK_comp4681_c0_seq1
258bp |
|
PREDICTED:_LOW_QUALITY_PROTEIN:_uncharacterized_protein_KIAA1109_[Bombyx_mori] |
| GO:0001558 |
P |
regulation of cell growth |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0030856 |
P |
regulation of epithelial cell differentiation |
|
| 9654 |
O_BomoSK18690_complete:A_BomoSK_comp14159_c0_seq1
163bp |
|
|
|
| 9655 |
O_BomoSK18691_complete:A_BomoSK_comp14159_c0_seq1
155bp |
|
|
|
| 9656 |
O_BomoSK18692_5prime_partial:A_BomoSK_comp14159_c0_seq1
128bp |
|
|
|
| 9657 |
O_BomoSK18693_complete:A_BomoSK_comp14159_c0_seq1
125bp |
|
|
|
| 9658 |
O_BomoSK18694_complete:A_BomoSK_comp14159_c0_seq1
115bp |
|
|
|
| 9659 |
O_BomoSK18695_5prime_partial:A_BomoSK_comp14159_c0_seq1
100bp |
|
|
|
| 9660 |
O_BomoSK18696_internal:A_BomoSK_comp14159_c0_seq2
141bp |
|
|
|